That is the problem with testing for blood alone. ColoAlert is a home bowel cancer screening test that looks for hidden blood and for tumour-associated DNA in the same stool sample, so a tumour that is not bleeding on the day you test still has a way of showing up.
Screening tests are designed for people who feel well. They are not the right tool for investigating a symptom, and using one can delay a diagnosis that needs urgent attention. Contact your GP without delay if you have:
Your GP can refer you urgently on the NHS. That route is faster and more thorough than any home test.
The NHS bowel screening programme uses a faecal immunochemical test, or FIT. It is a good test and it is free, but it does one thing: it detects human haemoglobin, meaning blood, in your stool. Bowel tumours and large polyps often bleed, so that works much of the time.
The difficulty is that bleeding is intermittent. A tumour may bleed one week and not the next. It may sit high in the bowel, where haemoglobin is partly broken down before it reaches the stool. A single FIT sample catches the day it is taken, and no more than that.
ColoAlert adds three things to that picture. Haptoglobin survives further along the bowel than haemoglobin, so blood originating higher up is less likely to be missed. KRAS and BRAF are genes that are frequently mutated in colorectal tumours, and cells shed from a tumour carry those mutations into the stool whether or not the tumour is bleeding. hDNA measures the overall quantity of human DNA in the sample, which tends to rise when bowel cells are being shed abnormally fast.
Together they give five independent signals from one sample instead of one.

You collect a stool sample at home using the tubes provided. One tube contains a DNA stabiliser, which preserves any genetic material until the sample reaches the laboratory. You post it back in the prepaid packaging, and it travels to biovis Diagnostik MVZ GmbH in Limburg-Eschhofen, Germany.
There the haemoglobin and haptoglobin are measured by ELISA, and the KRAS, BRAF and hDNA markers by quantitative PCR. biovis is accredited to DIN EN ISO 15189, the international quality standard for medical laboratories, and the test set is manufactured by biovis as an in-house medical device.



Adults aged 45 and over who have no bowel symptoms. That age matters: bowel cancer rates begin climbing from the mid-forties, while the NHS programme starts inviting people at 50 in most of the UK, leaving a window where screening is worth doing but not yet offered.
It is also worth considering if you have a family history of bowel cancer, if you want to screen between NHS invitations, or if you would simply rather not wait. It is not a replacement for the NHS programme, and you should still take part when you are invited.
Anyone with symptoms. If you have bleeding, a persistent change in bowel habit, unexplained weight loss, ongoing abdominal pain or new unexplained tiredness, a screening test is the wrong tool and it may cost you time. See your GP, who can refer you urgently.
It is also unsuitable during menstruation, with actively bleeding haemorrhoids, with bleeding gums or gastritis, or during an episode of diarrhoea. Each of these can affect the result.

Testing for blood captures a tumour only on a day it happens to bleed. DNA markers are shed either way, which is why combining the two gives a second route to detection.
| NHS FIT | ColoAlert | |
|---|---|---|
| What it detects | Haemoglobin | Haemoglobin, haptoglobin, KRAS, BRAF, hDNA |
| Detects a non-bleeding tumour | Unlikely | Possible, via DNA markers |
| Age offered | From 50 in most of the UK | From 45, by choice |
| Frequency | Every two years | Every three years |
| Cost | Free | £324.99 |
| Who reads it | NHS screening programme | A named GP, GMC 4576963 |
ColoAlert is intended alongside the NHS programme, not instead of it. If you are invited for NHS screening, take part.



A stool test that looks for hidden blood and for tumour-associated DNA in the same sample. The DNA markers matter because a bowel tumour does not always bleed, and a test that looks only for blood can miss it. Recommended every three years from age 45 for people without symptoms.

£324.99, which includes delivery, the prepaid return, laboratory analysis of all five markers and GP review of anything abnormal. There are no add-on fees.
No. The NHS bowel cancer screening programme uses the FIT test, which is free and which you should take part in when you are invited. ColoAlert is a private test you can use alongside it, most often by people aged 45 to 49 who are not yet invited, or by people who want to test between NHS rounds.
FIT measures one thing, human haemoglobin. ColoAlert measures haemoglobin and haptoglobin by ELISA and, from the same sample, the tumour-associated markers KRAS, BRAF and hDNA by qPCR. The DNA markers are shed whether or not a tumour is bleeding, which is the point of adding them.
About ten days from posting — two to three days in transit and seven laboratory days, sent as a password-protected document. Posting on the day you collect, Monday to Thursday, is what keeps it to that.
Every three years for people without symptoms, unless a doctor advises differently. Continue with NHS screening invitations as well.
Performance figures for the test are those reported by the manufacturer, and we will provide them on request rather than quote a single headline number, because sensitivity varies by cancer stage and by which marker detects it. What matters practically is this: no stool test is a substitute for colonoscopy, an abnormal result needs investigating, and a normal result reduces but does not eliminate the possibility of disease.
A GP reviews the result and contacts you to talk it through at no extra cost. An abnormal result is not a diagnosis of cancer. It means further investigation is warranted, usually a colonoscopy, and you will be given clear written information to take to your own GP or to arrange it privately.
It is reassuring, but it is not a guarantee. Screening tests miss some cancers, and a result reflects the day the sample was taken. If you develop symptoms after a normal result, see your GP and do not wait for your next test.
biovis developed and runs the assay in their own accredited laboratory, and the test set is manufactured by them. biovis is part of the Sonic Healthcare group, one of the largest pathology groups in the world, and is accredited by the German national accreditation body to DIN EN ISO 15189:2024. Samples are analysed there exclusively. The DNA stabiliser in the collection tube is what makes the journey possible.
Monday to Thursday, on the day you collect. Not Friday, not over a weekend, not before a bank holiday, and never into a letterbox where it will sit. A sample delayed in transit can become unsuitable for analysis, and you would need to repeat it.
For three days before, avoid raw or undercooked meat, high-dose vitamin C and iron-containing supplements. Each can interfere with the measurement.
Some policies reimburse screening tests, but many exclude routine screening in people without symptoms. Check with your own insurer before ordering. You receive a full written report suitable for a claim.
£324.99 including free delivery and return. Results in about 10 days.
Order ColoAlert